VanEck Associates
MPT

VanEck Associates’s Medical Properties Trust MPT Stock Holding History

VanEck Associates’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$655K Sell
141,808
-915
-0.6% -$4.53K ﹤0.01% 1198
2026
Q1 		$661K Buy
142,723
+7,770
+6% +$40.5K ﹤0.01% 1146
2025
Q4 		$675K Buy
134,953
+12,058
+10% +$62.8K ﹤0.01% 1132
2025
Q3 		$623K Buy
122,895
+11,974
+11% +$52.7K ﹤0.01% 1157
2025
Q2 		$478K Sell
110,921
-7,301
-6% -$36.1K ﹤0.01% 1167
2025
Q1 		$713K Sell
118,222
-133,966
-53% -$677K ﹤0.01% 1095
2024
Q4 		$996K Buy
252,188
+229
+0.1% +$1.03K ﹤0.01% 1033
2024
Q3 		$1.19M Buy
251,959
+27,597
+12% +$136K ﹤0.01% 977
2024
Q2 		$967K Sell
224,362
-8,833
-4% -$42.3K ﹤0.01% 996
2024
Q1 		$1.1M Buy
233,195
+24,085
+12% +$92.2K ﹤0.01% 969
2023
Q4 		$1.03M Buy
209,110
+26,719
+15% +$131K ﹤0.01% 958
2023
Q3 		$994K Buy
182,391
+4,260
+2% +$34.1K ﹤0.01% 902
2023
Q2 		$1.65M Sell
178,131
-39,277
-18% -$332K ﹤0.01% 764
2023
Q1 		$1.79M Buy
217,408
+55,296
+34% +$611K ﹤0.01% 727
2022
Q4 		$1.81M Buy
162,112
+12,188
+8% +$142K ﹤0.01% 693
2022
Q3 		$1.78M Sell
149,924
-67,339
-31% -$1.02M 0.01% 674
2022
Q2 		$3.32M Sell
217,263
-12,016
-5% -$216K 0.01% 557
2022
Q1 		$4.85M Buy
229,279
+182,979
+395% +$3.94M 0.01% 511
2021
Q4 		$1.09M Buy
46,300
+18,562
+67% +$398K ﹤0.01% 829
2021
Q3 		$557K Buy
27,738
+2,553
+10% +$52.3K ﹤0.01% 897
2021
Q2 		$506K Sell
25,185
-746
-3% -$16K ﹤0.01% 905
2021
Q1 		$552K Sell
25,931
-58,753
-69% -$1.26M ﹤0.01% 838
2020
Q4 		$1.84M Buy
84,684
+7,783
+10% +$152K 0.01% 559
2020
Q3 		$1.36M Sell
76,901
-40,275
-34% -$749K ﹤0.01% 573
2020
Q2 		$2.2M Sell
117,176
-19,182
-14% -$340K 0.01% 467
2020
Q1 		$2.36M Buy
136,358
+22,850
+20% +$478K 0.01% 420
2019
Q4 		$2.4M Buy
113,508
+6,355
+6% +$129K 0.01% 487
2019
Q3 		$2.1M Buy
+107,153
New +$1.97M 0.01% 475

Other funds holding MPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

VanEck Associates's MPT Position: Q2 2026 in Review

VanEck Associates reduced its Medical Properties Trust (MPT) stake by 0.64% in Q2 2026, selling an estimated $4.53K and leaving 141,808 shares worth $655K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

VanEck Associates first reported a position in MPT in Q3 2019 and has held it in 28 quarters since. The position peaked at $4.85M in Q1 2022. 488 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • VanEck Associates held 141,808 shares of Medical Properties Trust worth $655K as of Q2 2026.
  • VanEck Associates sold 915 Medical Properties Trust shares in Q2 2026, an estimated $4.53K.
  • Medical Properties Trust made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1198 holding.
  • VanEck Associates first reported a position in Medical Properties Trust in Q3 2019 and has held it in 28 quarters since.
  • VanEck Associates's Medical Properties Trust position peaked at $4.85M in Q1 2022.
  • 488 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.